Updated tip design to maximise deliverability1,2,3,4
Advanced Shaft Technology for effective and reliable deliverability1,5,6,7
Abluminal bioresorbable gradient coating technology built on the heritage of the UltimasterTM Stent2,8
The Ultimaster™ Tansei™ Sirolimus eluting coronary stent system facilitates enhanced deliverability even in the most challenging cases, thanks to its advanced shaft technology and an innovative tip.1,3,4,5,6,7
Its stainless steel tapered core wire at the exit port and stronger hypotube enhance pushability and provide excellent kink resistance.5,6,7
It also features a highly flexible, durable and visible tip supporting navigation through tortuous vessels and reduce the risk of tip damage when navigating challenging anatomy.1,2,3,4
Building on the heritage of Ultimaster™ with its proven clinical performance, Ultimaster™ Tansei™ utilises the same abluminal gradient bioresorbable polymer coating to support early vascular repair.2,8,9,10
- Sirolimus-eluting, abluminal bioresorbable polymer coating designed for targeted healing9,11
- Simultaneous polymer resorption and drug release within 3 – 4 months, aligning with natural vessel healing11,12
- Gradient drug coating - no drug coating on the parts of the stent that experience the most physical stress - designed to ensure polymer integrity even during overexpansion minimizing the risk of cracking or delamination2,9
- PCL added to PDLLA to increase elasticity and coating durability11
The Ultimaster™ Tansei™ Sirolimus eluting coronary stent system features a refined tip design engineered to enhance deliverability in complex anatomies1,2,3,4
- Flexible tip material supports navigation through tortuous and angulated vessels1,3,4
- Durable tip material to reduce the risk of tip damage when navigating challenging anatomy3,4
- Rounded tip shape for low passing resistance1,3,4
- Brightly colored, easily visible red tip aids guidewire loading2
The advanced shaft design of the Ultimaster™ Tansei™ Sirolimus eluting coronary stent system is engineered to provide optimal pushability and excellent kink resistance.1,5,6,7
- Stainless steel core wire reinforcement: Guidewire exit port reinforced via tapered stainless steel core wire, designed to ensure smooth and balanced transition of stiffness and pushability across the entire system7.
- Enhanced hypotube design: Maximises kink resistance for reliable deliverability1,5,6
The Ultimaster™ Tansei™ Sirolimus eluting coronary stent system is specifically designed to address the challengesof complex bifurcation anatomy :
- Open cell, 2-link design facilitates side branch access, intendedto support effective bifurcation stenting2,13,14,15
- Uniform scaffolding provides optimal coverage acrossbifurcation lesions2,14,15
Ultimaster™ Tansei™ Sirolimus eluting coronary stent system offers streamlined overexpansion capacity:
- Post-dilatation limit up to 5.5 mm for effective lesion coverage2,16
- Independent bench tests demonstrate expansion capacity up to 5.8 mm2,16,17
Over 50,000 patients enrolled in the Ultimaster™ clinical program, including complex patient subgroups.19
- Demonstrated optimal vascular repair.10
- Long-term safety and efficacy confirmed in randomised controlled trials and real-world practice.20,21
- CE marked for patients at high bleeding risk, including those eligible for dual antiplatelet therapy (DAPT) as short as one month16 (Master Dapt Study)
Ultimaster™ Family: A Top Choice DES for High‑Bleeding Risk Patients22,23,24
The Ultimaster™ Sirolimus eluting coronary stent systems (including Ultimaster Nagomi™ and Ultimaster™ Tansei™) are MDR‑certified and recommended for patients at high-bleeding risk (HBR), including those eligible for just 1‑month DAPT—supported by robust clinical data from the MASTER DAPT trial and registries22,25,26
Read our comprehensive study summary and learn how more than 2.9 million patients have benefited from a stent belonging to the Ultimaster™ stent family18
References
Disclaimer
Not all products are available for sale in all countries. This information is provided only in respect to markets where these products are approved or cleared. Please contact your Terumo local sales representative for more information. Refer to Instructions for Use for contraindications, warnings, precautions and additional information. All brand names are trademarks or registered trademarks owned by TERUMO CORPORATION, its affiliates, or unrelated third parties.
Didn't find your product?
Consult our products in our Product Index